Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
In vivo experiments have established that this receptor on dendritic cells facilitates potent T dependent germinal center-based B cell responses and is likely crucial for facilitating antigen presentation to antigen-specific B cells and enhancing T-B cell collaboration against bacterial lipoproteins and other albumin-binding microbial proteins.
Abstract
The phenomenon of albumin-hitchhiking has been exploited in vaccination strategies. We hypothesized that albumin mediated protein delivery may have evolved to facilitate the presentation of conformational determinants directly to B cells to facilitate B cell activation. However, the receptor that potentially targets albumin to lymph nodes and facilitates the presentation of intact proteins to B cells has hitherto not been identified.
Surface binding, specificity and saturability studies were performed on human and murine immune cells. Membrane proteins were extracted from human Ramos B cell membranes and affinity chromatography was performed using an HSA (human serum albumin)-Sepharose matrix. Mass spectrometry was performed on eluted proteins. CRISPR/Cas9 mediated gene ablation was used to establish the identity of the HSA-receptor (HSA-R). HEK 293T cells were transfected with the cDNA for the HSA-R. In vitro culture of murine dendritic cells with HSA and HSA-bound proteins and immunization of a range of genetically altered recipient mice was performed to establish the in vivo function of the HSA-R.
We purified the HSA-R using affinity chromatography and validated its identity using gene ablation and overexpression studies. CRISPR/Cas9 mediated gene ablation and overexpression in HEK 293T cells helped establish that the HSA-R is both necessary and sufficient to exhibit albumin on the surface of antigen presenting cells for at least 15 hours. In vivo experiments have established that this receptor on dendritic cells facilitates potent T dependent germinal center-based B cell responses.
A newly discovered poorly endocytic but specific albumin receptor on antigen presenting cells is likely crucial for facilitating antigen presentation to antigen-specific B cells and enhancing T-B cell collaboration against bacterial lipoproteins and other albumin-binding microbial proteins.
n/a
Immune Response Regulation: Cellular Mechanisms (IRC)
It is shown that substantive improvements in cytosolic antigen delivery provided by the fusion-dependent mini-protein ZF5.3 result in concomitant improvements in MHC-I-mediated antigen presentation and B3Z T-cell activation, which could improve the design of peptide vaccines for immunotherapy.
Teresia Chen, Michel DuPage, Alanna Schepartz· bioRxiv· 0 citations
This paper delineates the methodologies for detecting TLR9 on mammalian RBCs and isolating and preparing murine RBCs for transfusion, as well as for binding CpG DNA oligodeoxynucleotides to RBCs for both in vitro and in vivo studies.
E. Oatman, L. Sayegh, N. Mangalmurti· Methods in molecular biology· 0 citations
It is demonstrated that the PERV p15E protein can modulate cytokine release by human immune cells and suppress their cytotoxic activity, which may have potential applications in protecting transplanted tissues from immune-mediated rejection.
Jin-Zhao Ban, A. Schienke, Maike Quotschalla et al.· International Journal of Mol...· 0 citations
This work will examine the development and use of B cell tetramers for the purpose of studying antigen-specific B cell responses following RBC transfusion.
Leon Zheng, Hirotomo Nakahara, S. Cattani et al.· Methods in molecular biology· 0 citations
It is shown that tumor-associated macrophages are the dominant nonmalignant albumin-accumulating population in mouse tumors and exhibit the highest per-cell uptake and albumin conjugation prolonged STING-agonist circulation and improved antitumor efficacy versus free agonist in syngeneic tumors.
Hui-Yu Hu, F. Jiang, S. Park et al.· Cell Reports· 0 citations
The genetic engineering of chimeric antigen receptor T (CAR-T) cells provides a means of generating large numbers of T cells specific for a single antigen, and these cells have attracted increasing interest as a treatment in diseases associated with inflammation.
S. Gieseg, B. Hock, M. Ogugofor et al.· Annals of Translational Medi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.